YaoGeJu

Company directoryChina company filings

Zhejiang Better Pharmaceuticals Co., Ltd.

As of 18 November 2026, for the company name Zhejiang Better Pharmaceuticals Co., Ltd. as recorded, the chemical-drug catalogue lists 5 active records with this name as holder; 5 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

9 acceptance records as first applicant, grouped into 6 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Finerenone Tablets 2 records · Latest accepted 2025/08/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502889Generic2025/08/09Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
CYHS2502888Generic2025/08/09Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Lacidipine Tablets 2 records · Latest accepted 2025/06/14

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502140Generic2025/06/14Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
CYHS2502139Generic2025/06/14Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Glucosamine Sulfate Capsules 1 records · Latest accepted 2025/03/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500987Generic2025/03/10Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Roxadustat Capsules 2 records · Latest accepted 2025/02/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500663Generic2025/02/09Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
CYHS2500662Generic2025/02/09Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Mesalazine Enteric-coated Tablets 1 records · Latest accepted 2024/04/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401088Generic2024/04/12Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Simvastatin Tablets 1 records · Latest accepted 2021/10/11

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150903Supplement2021/10/11Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Finerenone Tablets CYHS2502889Generic2025/08/09Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Finerenone Tablets CYHS2502888Generic2025/08/09Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Lacidipine Tablets CYHS2502140Generic2025/06/14Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Lacidipine Tablets CYHS2502139Generic2025/06/14Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗

Catalogue holder records

5 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Roxadustat CapsulesZhejiang Better Pharmaceuticals Co., Ltd.Zhejiang Better Pharmaceuticals Co., Ltd.国药准字H202649132026/06/23Generic approved under the new chemical-drug registration classificationCDE ↗
Roxadustat CapsulesZhejiang Better Pharmaceuticals Co., Ltd.Zhejiang Better Pharmaceuticals Co., Ltd.国药准字H202649122026/06/23Generic approved under the new chemical-drug registration classificationCDE ↗
Simvastatin TabletsZhejiang Better Pharmaceuticals Co., Ltd.Zhejiang Better Pharmaceuticals Co., Ltd.国药准字H201034982023/02/03Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Clarithromycin TabletsZhejiang Better Pharmaceuticals Co., Ltd.Zhejiang Better Pharmaceuticals Co., Ltd.国药准字H200832812020/03/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Glucosamine Sulfate CapsulesZhejiang Better Pharmaceuticals Co., Ltd.Zhejiang Better Pharmaceuticals Co., Ltd.国药准字H202658582026/09/02Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

5 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
克拉霉素 · No verified English nameZhejiang Better Pharmaceuticals Co., Ltd.Y20190008728A2025/12/31CDE ↗
拉西地平 · No verified English nameZhejiang Better Pharmaceuticals Co., Ltd.Y20190007062A2023/03/24CDE ↗
泮托拉唑钠 · No verified English nameZhejiang Better Pharmaceuticals Co., Ltd.Y20190004817A2025/01/21CDE ↗
阿奇霉素 · No verified English nameZhejiang Better Pharmaceuticals Co., Ltd.Y20190004814A2025/03/04CDE ↗
艾司奥美拉唑钠 · No verified English nameZhejiang Better Pharmaceuticals Co., Ltd.Y20170000377A2023/03/24CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

7 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Bepotastine Besilate Orally Disintegrating Tablets CYHB2401631Supplement2024/10/12Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Levodopa and Benserazide Hydrochloride Tablets CYHS2303132Generic2023/11/15Guangdong Wen Jian Pharma Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Bepotastine Besilate Orally Disintegrating Tablets CYHS2102189Generic2021/12/14Hong Yue Technology (Hu Zhou) Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Ceftriaxone Sodium for Injection CYHB2101416Supplement2021/06/18Hangzhou Sen Ze Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Cefotaxime Sodium For Injection CYHB2101407Supplement2021/06/18Hangzhou Sen Ze Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Cefuroxime Sodium for Injection CYHB2101406Supplement2021/06/18Hangzhou Sen Ze Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗
Cefoperazone Sodium and Sulbactam Sodium for Injection CYHB2101405Supplement2021/06/18Hangzhou Sen Ze Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Better Pharmaceuticals Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.